3Boyle PJ, King AB, OlanskyL et al. Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a restrospective review of randomly selected medical records. Clin Ther, 2002;2493: 378～ 39 被引量：1
4Hallsten K, Virtanen KA, Lonnqvist F et al. Rosiglitazone not metformin enhances insulin - and exercise - stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes. Diabetes, 2002; 51 (12): 3479～3485 被引量：1
5A Diabetes Outcome Progression Trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2diabetes. Diabetes Care, 2002; 25 (10): 1734～1743 被引量：1
6Lebovitz HE, Kreider M, Freed MI. Evaluation of liver function in type 2 diabetic patients during clinical trial: evidence that rosiglitazone does not cause hepatic dysfunction.Diabetes Care, 2002; 25 (5): 815～821 被引量：1
7Matthews DR. Guidance on rosiglitazone for type 2 diabetes mellitus. Lancet, 2001; 357 (9254): 481 被引量：1
8Stumvoll M, Haring MH. Glitazones: Clinical effects and molecular mechanisms. Ann Med, 2002; 34 (3): 217-224 被引量：1
9Gomez- Perrez FJ, Fanfhanel- Salmon G, Antonio- Barbose J et al. Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes. Diabetes Metab Res Rev, 2002; 18 (2): 127-134 被引量：1
10Wolffenbuttel BH, Gomis R, Squatrito S et al. Addition of low dose rosiglitazone to sulphonylurea therapy improves glycemic control in type 2 diabetic patients. Diabet Med,2000; 17 (1): 40-47 被引量：1
